Cyltezo(adalimumab-adbm)
CYLTEZO 10 MG in 0.2 ML Prefilled Syringe
Dosage & Administration
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis :
Juvenile Idiopathic Arthritis :
Pediatric Weight 2 Years of Age and Older | Recommended Dosage |
---|---|
10 kg (22 lbs) to less than 15 kg (33 lbs) | 10 mg every other week |
15 kg (33 lbs) to less than 30 kg (66 lbs) | 20 mg every other week |
30 kg (66 lbs) and greater | 40 mg every other week |
Crohn's Disease :
Pediatric Weight | Recommended Dosage | |
---|---|---|
Days 1 and 15 | Starting on Day 29 | |
17 kg (37 lbs) to less than 40 kg (88 lbs) | Day 1: 80 mg Day 15: 40 mg | 20 mg every other week |
40 kg (88 lbs) and greater | Day 1: 160 mg (single dose or split over two consecutive days) Day 15: 80 mg | 40 mg every other week |
Ulcerative Colitis :
Plaque Psoriasis or Adult Uveitis :
Hidradenitis Suppurativa :
Get Your Patient on Cyltezo
See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:
Cyltezo Prescribing Information
Cyltezo Prior Authorization Resources
Most recent state uniform prior authorization forms
Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form
Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form
Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form
Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form
Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form
Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form
Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form
Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form
Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form
Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form
Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form
Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form
Benefits investigation
Reimbursement help (FRM)
Cyltezo Financial Assistance Options
Copay savings program
Learn More
Overview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Cyltezo PubMed™ News
Cyltezo Patient Education
Getting started on Cyltezo
Instructions For Use: Rheumatoid Arthritis (RA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Juvenile Idiopathic Arthritis (JIA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Psoriatic Arthritis (PsA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Ankylosing Spondylitis (AS)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Crohn’s Disease (CD)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Ulcerative Colitis (UC)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Hidradenitis Suppurativa (HS)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Adult Uveitis (UV)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use: Plaque Psoriasis (PsO)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Cyltezo Prefilled Syringe Injection Checklist
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Juvenile Idiopathic Arthritis (JIA) Dosing Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Ankylosing Spondylitis (AS) Dosing Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Hidradenitis Suppurativa (HS) Dosing Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Open Camera on Phone
Scan QR Code & Tap Link
Cyltezo FAQs
How is the dosage of Cyltezo?
Cyltezo is available in 10 dosages, including 100 mg/ml Prefilled Syringe 0.4 ml, 50 mg/ml Auto-Injector 0.8 ml, 50 mg/ml Prefilled Syringe 0.8 ml, 50 mg/ml Prefilled Syringe 0.2 ml, 50 mg/ml Prefilled Syringe 0.4 ml, mixed Pack, mixed Pack, mixed Pack, mixed Pack and 100 mg/ml Auto-Injector 0.4 ml
What does Cyltezo treat?
Cyltezo treats Arthritis, Juvenile, Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease, Spondylitis, Ankylosing, Uveitis, Arthritis, Psoriatic and Hidradenitis Suppurativa
What is Cyltezo made of?
Cyltezo contains adalimumab which is a Tumor Necrosis Factor Blocker
How Is Cyltezo Administered?
Cyltezo is administered as a Injectable or Pack
What Are The Cyltezo Mechanism Of Action?
Cyltezo mechanism of action is Tumor Necrosis Factor Receptor Blocking Activity
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available